SCHEMBL19207891

SCHEMBL19207891

CN1C(=O)C(NC(=O)c2nnc(Cc3ccccc3)s2)[C@H]2C[C@H]2c2nccnc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19207530 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19224702 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19224703 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19880650 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19207890 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19805527 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19228567 1.00 RIPK1 (1.00) RIPK1
SCHEMBL19224627 0.89 RIPK1 (1.00) RIPK1
SCHEMBL19879524 0.89 RIPK1 (1.00) RIPK1
SCHEMBL20050216 0.89 RIPK1 (1.00) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed